Episurf Medical updates about upcoming investor presentations

Episurf Medical (Nasdaq: EPIS B) announces that the company will participate in the following investor conferences during November and December:

November 14, Vator Global Healthcare Days Wien

November 19, Redeye Life Science Day, Stockholm

November 27, Vator Unicorn Summit, Stockholm

December 4, Vator Global Healthcare Days Tel Aviv

The company will be represented by CEO Pål Ryfors, and in specific presentations by additional members from the company’s management team.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

Tags: